XYL.NYSEXylem INC

10-Q: Xylem Inc. Q1 2026 Revenue Up 2.7%, Driven by FX; Profitability Improves

Sentiment:

Quarterly Report


Xylem Inc. reported a 2.7% increase in first-quarter 2026 revenue to $2.125 billion, driven by favorable foreign currency impacts, with net income attributable to Xylem rising 14.2% to $193 million.

Summary

  • Xylem Inc. reported first-quarter 2026 revenue of $2.125 billion, a 2.7% increase from $2.069 billion in the prior year period.
  • This revenue growth was primarily attributed to a $65 million favorable foreign currency impact, partially offset by a $9 million organic revenue decline.
  • Orders increased by 3.2% to $2.228 billion, though organic orders saw a slight decrease of 0.3%.
  • Net income attributable to Xylem increased by 14.2% to $193 million, resulting in diluted earnings per share of $0.79, up from $0.69 in the prior year.
  • Net income as a percentage of revenue improved to 9.1% from 8.2% in the prior year.
  • Adjusted EBITDA margin was 20.6%, a 20 basis point increase compared to the prior year.
  • The company is raising its full-year 2026 total revenue growth outlook to 2% to 3% and maintaining its organic revenue growth outlook at 2% to 4%.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with revenue growth, improved profitability, and an increased full-year outlook, despite some organic revenue softness and a declining backlog.

Positives

  • Revenue increased by 2.7% to $2.125 billion, driven by favorable foreign currency impacts.
  • Net income attributable to Xylem increased by 14.2% to $193 million.
  • Diluted earnings per share rose to $0.79 from $0.69 in the prior year.
  • Net income margin improved to 9.1% from 8.2%.
  • Adjusted EBITDA margin increased by 20 basis points to 20.6%.
  • Gross margin increased by 70 basis points to 37.8%, driven by productivity savings and price realization.
  • Operating income increased by 5.6% to $244 million, with operating margin improving by 30 basis points.
  • Orders increased by 3.2% to $2.228 billion.
  • The company raised its full-year revenue growth outlook.

Negatives

  • Organic revenue declined by 0.4% ($9 million) for the quarter.
  • Organic orders decreased by 0.3%.
  • Backlog decreased by 7.5% to $4.712 billion compared to the prior year, primarily due to strong backlog execution outpacing order intake.
  • Restructuring and asset impairment charges increased to $31 million from $21 million in the prior year.
  • SG&A expenses increased by $12 million, driven by unfavorable currency impacts, inflation, and strategic investments.

Risks

  • The company faces risks from overall industry and general economic conditions, including spending, interest rates, and market strength.
  • Geopolitical matters, including conflicts and trade protectionism, pose risks to global sales and operations.
  • Manufacturing and operating cost increases due to inflation, supply chain issues, and labor shortages are a concern.
  • Cybersecurity incidents and data breaches could disrupt operations and customer reliance on IT systems.
  • Lack of availability or delays in receiving critical components like semiconductors could impact operations.
  • Failure to successfully execute large projects, including performance guarantees and customer budget constraints, presents a risk.
  • The company's ability to retain and attract key talent and labor is critical.
  • Changes in laws or regulations, including those related to AI, data privacy, and environmental standards, could impact the business.
  • Volatility in served markets or impacts from weather conditions and climate patterns are potential challenges.

Future Outlook

Xylem is raising its total revenue growth outlook for 2026 to 2% to 3% and maintaining its organic revenue growth outlook at 2% to 4%. This outlook is provided in the context of current volatility, including geopolitical, trade, macroeconomic, and regulatory uncertainty.

Management Comments

  • "Xylem reported revenue for the first quarter of 2026 of $2,125 million, an increase of 2.7% compared to $2,069 million reported in the first quarter of 2025."
  • "The revenue increase consisted primarily of favorable foreign currency impacts of $65 million, or 3.1%, partially offset by slight organic declines of $9 million, or 0.4%."
  • "Orders of $2,228 million, up 3.2% from $2,158 million in the prior year period, and down 0.3% on an organic basis."
  • "Earnings per share of $0.79, up 14.5% compared to prior year ($1.12, up 8.7% versus prior year, on an adjusted basis)."
  • "Net income attributable to Xylem as a percent of revenue of 9.1%, up 90 basis points compared to 8.2% in the prior year."
  • "Adjusted EBITDA margin of 20.6%, up 20 basis points when compared to 20.4% in the prior year."
  • "We are raising our total revenue growth outlook to 2% to 3%, and maintaining our organic revenue growth outlook at 2% to 4% in 2026."

Industry Context

StockSavvy.ai notes that Xylem's performance in Q1 2026, with revenue growth driven by foreign exchange and improved profitability, aligns with broader trends in the industrial sector where companies are navigating inflationary pressures and supply chain complexities. The focus on productivity savings and price realization suggests a strategic response to these macro-economic challenges.

Comparison to Industry Standards

  • Xylem's reported revenue growth of 2.7% for Q1 2026, while positive, is moderate compared to some high-growth industrial technology peers. However, the improvement in net income margin (9.1% vs 8.2%) and adjusted EBITDA margin (20.6% vs 20.4%) indicates effective operational management and cost control.
  • The company's focus on productivity savings (310 bps in gross margin, 430 bps in operating margin) and price realization (110 bps in gross margin, 150 bps in operating margin) are key strategies for maintaining profitability amidst inflation (240 bps impact on gross margin, 300 bps on operating margin). This approach is common among established players in the water technology sector seeking to offset cost pressures.
  • The decline in backlog (7.5% year-over-year) is a point of attention. While attributed to strong execution, it contrasts with companies in sectors experiencing order backlogs due to supply constraints, suggesting Xylem may be managing its order book more actively or facing specific market demand shifts.
  • The company's commitment to R&D (2.6% of revenue) is consistent with industry benchmarks for technology-driven companies, aiming to maintain a competitive edge in areas like smart metering and advanced water treatment solutions.

Legal Proceedings

  • The company is involved in various legal and regulatory proceedings incidental to its business operations, including environmental, tax, intellectual property, and contractual disputes.
  • A pending tax litigation matter in Sweden related to an intercompany IP transfer is ongoing, with the STA appealing a recent ruling in Xylem's favor.
  • The company has accrued $4 million for general legal matters as of March 31, 2026.

Stakeholder Impact

  • Shareholders: The increase in net income and EPS, along with the raised revenue outlook, is positive for shareholders. Significant share repurchases ($563 million in Q1 2026) also indicate a return of capital to shareholders.
  • Employees: The company incurs restructuring charges, which may involve workforce adjustments. Share-based compensation expense was $13 million in Q1 2026, indicating ongoing equity incentives.
  • Suppliers: Xylem facilitates voluntary supply chain financing programs with third-party institutions, with $234 million outstanding under these programs as of March 31, 2026.
  • Creditors: The company maintains investment-grade credit ratings and has significant available liquidity ($1.8 billion), suggesting a stable position for creditors.

Next Steps

  • The company expects to incur between $40 and $55 million in restructuring costs for the full year 2026.
  • The company is raising its total revenue growth outlook for 2026 to 2% to 3%.
  • The company is maintaining its organic revenue growth outlook at 2% to 4% for 2026.
  • The company expects approximately 60% of its current backlog to be recognized as revenue in the remainder of 2026.
  • The company expects to close an acquisition of a company specializing in optical sensing and measurement systems in 2026.

Key Dates

DateDescription
2025-01-01Beginning of the period for Condensed Consolidated Statements of Comprehensive Income and Condensed Consolidated Statements of Cash Flows.
2025-01-31Acquisition of Simply Clean Air and Water, Inc.
2025-02-07Completion of divestiture of Evoqua Magneto business.
2025-03-31End of the period for Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Cash Flows.
2025-04-01Beginning of the second quarter of 2025; Acquisition of Vacom Systems, LLC.
2025-07-23Acquisition of EMX Holdings, Inc.
2025-12-02Acquisition of Pac Machine Company.
2025-12-31End of fiscal year 2025; Balance sheet date.
2026-01-01Beginning of the period for Condensed Consolidated Income Statements, Condensed Consolidated Statements of Comprehensive Income, Condensed Consolidated Balance Sheets, and Condensed Consolidated Statements of Cash Flows.
2026-02-25Authorization of a new share repurchase program of up to $1.5 billion.
2026-03-25Company entered into a definitive agreement to acquire a company specializing in optical sensing and measurement systems.
2026-03-31End of the period for Condensed Consolidated Income Statements, Condensed Consolidated Statements of Comprehensive Income, Condensed Consolidated Balance Sheets, and Condensed Consolidated Statements of Cash Flows.
2026-04-24Date as of which outstanding shares of common stock were reported.
2026-04-28Date of the report and certifications.

Recommendation

hold

The company demonstrates solid operational execution with improved profitability and an optimistic revenue outlook, supported by strategic cost management and favorable currency tailwinds. However, the slight organic revenue decline, decrease in backlog, and ongoing restructuring charges warrant a cautious approach. While the company is performing well, the broader economic uncertainties and the moderate organic growth suggest a 'hold' rating until clearer signs of sustained organic expansion emerge.

Keywords

Xylem Inc., Form 10-Q, Quarterly Report, Water Technology, Revenue, Net Income, Earnings Per Share, Orders, Backlog, EBITDA, Financial Results, Q1 2026

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.